Ron Johnson actually said...

What is the harm in doing this, in terms of--versus the benefit of giving people hope?

I want to get to the real crux of the problem here, because I think we are confusing the approval rate versus the ability of a patient like ...

The cost. Companies develop drugs because, in the end, they are reporting to shareholders and they have to make a profit.

There is just something, in terms of the FDA making these decisions for parents and patients, that we have to come to grips with.